Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

Clinical trial NCT00472290 · COMPLETED

Trial details

NCT number: NCT00472290
Sponsor: Amgen
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Hematology MDS Myelodysplastic Syndromes Thrombocytopenia

Start date: 2007-04-01
Primary completion: 2011-07-18
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.